• Mustafa Kaya, Davut Ceylan, Tibet Kacira, Muhammet Talha Yener, Ali Eman, Huseyin Cakiroglu, Erdem Cokluk, and Nureddin Cengiz.
• Department of Neurosurgery, Sakarya Universty Faculty of Medicine, Sakarya, Turkey. Electronic address: mkaya2834@gmail.com.
• World Neurosurg. 2024 Jul 1; 187: e825e831e825-e831.

BackgroundEugenol has various curative properties. It affects the dilatation of cerebral arteries through voltage-dependent Ca2+ channel inhibition. This study is the first to explore the impact of eugenol on neuroprotection and vasospasm in an experimental subarachnoid hemorrhage (SAH) model.MethodsTwenty-four adult male Sprague-Dawley rats were indiscriminately separated into 3 groups: the control group (n = 8), the SAH group (n = 8), and the eugenol group (n = 8). A double-bleeding method was used. The eugenol group received intracisternal eugenol (Sigma-Aldrich, St. Louis, MO, USA) at 30 μg/20 μl after induction of SAH. On the day 7, all groups were euthanized. Measurements were taken for basilar artery wall thickness, lumen diameter, serum endothelin-1 (ET-1), and caspase-3 levels.ResultsThe eugenol group exhibited significantly lower wall thickness, ET-1, oxidative stress index, and caspase-3 levels compared to the SAH group. In comparison to the control group, the eugenol group showed a higher oxidative stress index along with higher ET-1 and caspase-3 levels, but these differences were not statistically significant. Wall thickness was significantly higher in the eugenol group than in the control group.ConclusionsThis study represents the first literature exploration of intrathecal eugenol's impact on vasospasm induced after experimental SAH. Administration of intrathecal eugenol demonstrates a positive effect on the treatment of experimental vasospasm as well as on the reduction of oxidative stress and apoptosis.Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

35 keywords...

hide…